In a previous study, Lee et al. showed that intraperitoneal administration of PPY exerts profound inhibitory effects on the accumulation of eosinophils in the airways while also reducing the levels of IL-4, IL-5, and IL-13 in the BAL fluid in an ovalbumin-induced asthma model [22]. Here, IL5 is linked to asthma.